Nausea  >>  granisetron intranasal (TRG)  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
granisetron intranasal (TRG) / Shin Nippon Biomedical Labs
NCT00787566: Phase 2 Study of Efficacy, Tolerability, and Safety of Intranasal Granisetron for Chemo-Induced Nausea and Vomiting

Completed
2
68
US
Intranasal granisetron, TRG
Shin Nippon Biomedical Laboratories, Ltd.
Chemotherapy-Induced Nausea and Vomiting
04/09
05/09

Download Options